2701 – Negative Association Between Neurological Soft Signs and Cannabis Use in Tunisian Patients with First-Episode Psychosis
Ahmed Mhalla, L. Gassab, Lotfi Gaha, Anouar Mechri
European Psychiatry 2013 DOI: 10.1016/s0924-9338(13)77316-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional observational study Peer reviewed |
|---|---|
| Sample size | 61 |
| Population | Inpatients with first-episode non-affective psychosis (53 men, 8 women; mean age 28.9 ± 9.4 years) |
| Measures | NSS scale of Krebs et al. (2000), Composite International Diagnostic Interview (CIDI) cannabis subsection |
| Topics | Cannabis |
| Key findings | Cannabis users had significantly lower NSS total scores than non-users (11.2 ± 5.6 vs 16.0 ± 6.7, p=0.04). The authors suggest cannabis may enhance the effects of genetic risk factors for psychosis, and call for more research on gene-environment interactions. |
Abstract
Introduction: Neurological soft signs (NSS) are minor or subtle neurological signs indicating non-specific cerebral dysfunction. They have been conceptualized as neurodevelopmental markers that mediate the biological propensity for the development of psychosis. Their interaction with the environmental factors such as cannabis use remains little studied.
Objective: To study the relationship between the NSS and the use of cannabis which is considered an environmental risk factor of psychotic disorder.
Methods: Sixty one in-patients (fifty three men and eight women; mean age: 28.9 ± 9.4 years) with a first-episode non affective psychosis according with DSM-IV were recruited. Neurological evaluations were carried-out by using the NSS scale of Krebs et al. (2000). We ascertained the use of cannabis with the cannabis subsection, included within the section of substance use, in the Composite International Diagnostic Interview (CIDI).
Results: The prevalence of cannabis use was 16.4%. The mean NSS total score was 15.3 ± 6.7. Significant lower NSS total score was found in cannabis users: 11.2 ± 5.6 versus 16.0 ± 6.7 (p=0.04). There was also an inverse but not significant relation between the use of cannabis and the motor coordination and the involuntary movements sub-scores.
Conclusions: Similar results have been reported in patients with schizophrenia and first-episode psychosis suggesting the existence of fewer NSS in the cannabis user patients. The cannabis could enhance the effects of genetic risk factors for psychosis. More work in the area of genetic-environment interactions in predicting psychosis is necessary.
Comparable studies
Other cross-sectional and survey studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... | 2011 | Observational cross-sectional study | n = 148 |
| Patterns of simultaneous polysubstance use in drug using university students Drug-using university students | 2006 | Cross-sectional survey | n = 149 |
| Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents | 2020 | Cross-sectional survey | |
| User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire | 2010 | Cross-sectional survey | n = 600 |
| Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... | 2012 | Cross-sectional survey | n = 337 |